The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...
Yavapai County will be part of the High Intensity Drug Trafficking Area program, which opens up federal resources to police ...
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
The Healthy on MSN1d
13 Supplement or Medication Combos You Should Never MixYou might turn to the mineral for help in staving off or shortening the duration of common colds, but you should know that ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...
PsyPost on MSN1d
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linkedA Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...
Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback